Monoclonal antibody desensitization in a patient with a generalized urticarial reaction following denosumab administration

Denosumab is a human monoclonal antibody indicated for the treatment of osteoporosis in postmenopausal women with a high risk of fractures. To our knowledge, no cases of desensitization to this drug have been described in the literature. We report the first case of generalized urticarial reaction an...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Allergy Asthma Clin Immunol
Egile Nagusiak: Gutiérrez-Fernández, D., Cruz, María-Jesús, Foncubierta-Fernández, A., Moreno-Ancillo, A., Fernández-Anguita, M. J., Medina-Varo, F., Andres-García, J. A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2015
Gaiak:
Case Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4620716/
https://ncbi.nlm.nih.gov/pubmed/26504466
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13223-015-0097-6
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak